With the decision by the Federal Court, people with drug dependencies who have been evaluated and diagnosed by a medical specialist can access disability insurance benefits. This in effect treats drug addiction in the same vein as a mental illness.
According to the court, the ruling, which was announced on Monday, was based on a thorough review of existing medical knowledge.
This reverses previous case law that viewed drug addiction as the individual’s responsibility and treatable through drug withdrawal. Up to now, individuals with drug addiction could only receive disability benefits if the addiction caused an illness or accident or if the dependency was the result of an illness.
As is the case with many other mental disorders, determining whether the person can receive disability benefits is based on a structured evaluation of whether the person can, despite the condition diagnosed medically, pursue suitable productive activity on a full-time or part-time basis.
In order to receive benefits, the person must pursue mitigation measures such as reasonable medical treatment. If the person refuses, benefits can be revoked.
The case that served as the basis for the decision was an appeal received by the court by a man dependent on benzodiazepines and opioids who had unsuccessfully applied for disability insurance. The judges concluded that the psychiatric expertise carried out on the person concerned, resulted in incapacity for work due to drug addiction.
More
More
Opioid painkiller prescriptions surge in Switzerland
This content was published on
Prescription for powerful opioid medication have increased twenty-fold in the last thirty years, a recent study has found.
International cooperation: the National Assembly accepts 11 billion euros
This content was published on
Switzerland's international cooperation strategy 2025-2028 has been recommended a budget of almost CHF11 billion after weeks of political wrangling.
Zurich court throws out ‘cum-ex’ case against German lawyer
This content was published on
A trial against a German lawyer, accused of breaching Swiss banking secrecy investigating 'cum-ex' transactions, has collapsed.
Swiss National Bank lowers key interest rate by 0.5%
This content was published on
The Swiss National Bank lowers benchmark interest rate by a surprisingly hefty 0.5%. The reference rate now stands at 0.5%.
Swiss fintech Leonteq has profits confiscated after regulatory breach
This content was published on
Swiss derivatives firm Leonteq acted in serious violation of regulatory obligations and must to hand over CHF9.3 million in profits.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Painkillers linked to heart attack risks
This content was published on
The report by researchers from Bern University, published in the British Medical Journal, looked at 31 clinical trials on more than 116,000 patients to examine the effects of painkillers on people’s health. The team studied data from existing large-scale studies comparing use of non-steroidal anti-inflammatory drugs (NSAIDs) as well as new-generation anti-inflammatory medicines (COX-2 inhibitors)…
This content was published on
In the U.S., abuse of opioids causes more death than firearms. But also in Switzerland, consumption is on the rise. A reason to worry?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.